<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(1)</volume><submitter>Cui X</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>MTHFD2 is a folate-coupled metabolic enzyme, which has been proved to participant in the metabolic reprogramming and tumor cell-sustaining proliferative capacity. However, the function of MTHFD2 in the development of ovarian cancer and its potential molecular mechanisms is still unclear.&lt;h4>Materials and methods&lt;/h4>The expression, various mutations, prognosis, and related network signaling pathways of MTHFD2 were analyzed using bioinformatics-related websites, including Oncomine, GEPIA, UCSC, cBioPortal, KM Plotter, TISIDB and TIMER. The prognostic value of MTHFD2 expression was validated by our own ovarian cancer samples using RT-qPCR. The migration ad invasion of ovarian cancer cells were further analyzed by CCK-8 and transwell assay. The Western-blot assay was perfor</pubmed_abstract><journal>Journal of ovarian research</journal><pagination>23</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8827288</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling.</pubmed_title><pmcid>PMC8827288</pmcid><pubmed_authors>Huo K</pubmed_authors><pubmed_authors>Jing X</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Cui X</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Su H</pubmed_authors><pubmed_authors>Wu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling.</name><description>&lt;h4>Background&lt;/h4>MTHFD2 is a folate-coupled metabolic enzyme, which has been proved to participant in the metabolic reprogramming and tumor cell-sustaining proliferative capacity. However, the function of MTHFD2 in the development of ovarian cancer and its potential molecular mechanisms is still unclear.&lt;h4>Materials and methods&lt;/h4>The expression, various mutations, prognosis, and related network signaling pathways of MTHFD2 were analyzed using bioinformatics-related websites, including Oncomine, GEPIA, UCSC, cBioPortal, KM Plotter, TISIDB and TIMER. The prognostic value of MTHFD2 expression was validated by our own ovarian cancer samples using RT-qPCR. The migration ad invasion of ovarian cancer cells were further analyzed by CCK-8 and transwell assay. The Western-blot assay was perfor</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2025-04-04T22:41:38.542Z</modification><creation>2024-12-04T12:03:24.675Z</creation></dates><accession>S-EPMC8827288</accession><cross_references><pubmed>35135596</pubmed><doi>10.1186/s13048-022-00954-w</doi></cross_references></HashMap>